In a report released Wednesday by the Office of the Inspector General at the US Health & Human Services, finds spending by the Medicare Part D program for compounded drugs rose 625 percent over the past decade. Read article here…….
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.